Taken together these results support the hypothesis that CD4+ T cells play an immunoregulatory tumor-promoting role in mice with EMT6 tumors, while CD8+ cells play a protective role in attenuating tumor growth-and that CD200 expression by tumor cells further modulates these effects. The gene discussed is CD4; the disease is neoplasm.